Surveillance in testicular cancer: Who, when, what and how?

Cancer Imaging

Volumn 7, Issue 1, 2007, Pages 145-147

  Sohaib, S A ^a   Husband, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Computed tomography; Germ cell tumour; Imaging; Testis cancer

Indexed keywords

FLUORODEOXYGLUCOSE;

CANCER RELAPSE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SURVEILLANCE; EDITORIAL; GERM CELL TUMOR; HEALTH CARE POLICY; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SEMINOMA; TESTIS CANCER; TESTIS NONSEMINOMA CANCER;

HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; SEMINOMA; TESTICULAR NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35648971020     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2007.0023     Document Type: Editorial

References (18)

1. Huddart RA, Joffe JK. Preferred treatment for stage I seminoma: a survey of Canadian radiation oncologists. Clin Oncol 2006; 18: 693-5.
2. Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet 2006; 367: 754-65.
3. Huddart RA, Norman A, Shahidi M, Horwich A. Coward D. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003; 21: 1513-23.
4. van den Belt-Dusebout AW, Nuver J, de Wit R, et al. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2006; 24: 467-75.
5. Travis LB, Fosså SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005; 97: 1354-65.
6. Sohaib SA, Huddart R, Dearnaley DP, Horwich A. Sensitivity of MRI in the diagnosis of retroperitoneal disease in testicular germ cell tumours. AJR Am J Roentgenol 2005; 184: suppl): 63.
7. Read G, Stenning SP, Cullen MH. et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 1992; 10: 1762-8.
8. Freedman LS, Parkinson MC, Jones WG, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 1987; 2: 294-8.
9. Harvey ML, Geldart TR, Duell R, Mead GM, Tung K. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer - a necessary risk? Ann Oncol 2002; 13: 237-42.
10. White PM, Howard GC, Best JJ, et al. The role of computed tomographic examination of the pelvis in the management of testicular germ cell tumours. Clin Radiol 1997; 52: 124-9.
11. Crawford SM, Rustin GJ, Begent RH, Newlands ES, Bagshawe KD. Safety of surveillance in the management of stage I anaplastic germ cell tumours of the testis. Br J Urol 1988; 61: 250-3.
12. Rustin GJ, Mead GM, Stenning SP, et al. Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - the National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol 2007; 25: 1310-5.
13. Lassen U, Daugaard G, Eigtved A. et al. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Eur J Nucl Med 2003; 30: 396-402.
14. Cremerius U, Wildberger JE, Borchers H, et al. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? - Results of a study in 50 patients. Urology 1999; 54: 900-4.
15. 18FDG PET in the prediction of relapse in patients with high risk clinical stage I non-seminomatous germ cell cancer (MRC study TE22), ECCO 13, the European Cancer Conference, Paris, Oct 30-Nov 3, 2005. Eur J Cancer): suppl 3): 227(abstract).
16. Warde P, Specht L, Horwich A. et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002; 20: 4448-52.
17. Oldenburg J, Martin JM, Fossa SD. Late relapses of germ cell malignancies: incidence, management, and prognosis. J Clin Oncol 2006; 24: 5503-11.
18. Dieckmann KP, Albers P, Classen J, et al. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases. J Urol 2005; 173: 824-9.